0001628280-22-005118.txt : 20220304 0001628280-22-005118.hdr.sgml : 20220304 20220304161007 ACCESSION NUMBER: 0001628280-22-005118 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220302 FILED AS OF DATE: 20220304 DATE AS OF CHANGE: 20220304 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Huizinga Robert Bindert CENTRAL INDEX KEY: 0001837648 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36421 FILM NUMBER: 22714150 MAIL ADDRESS: STREET 1: #1203-4464 MARKHAM STREET CITY: VICTORIA STATE: A1 ZIP: BC V8Z7X8 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aurinia Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001600620 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: #1203-4464 MARKHAM STREET CITY: VICTORIA BC STATE: A1 ZIP: V8Z 7X8 BUSINESS PHONE: 250-708-4272 MAIL ADDRESS: STREET 1: #1203-4464 MARKHAM STREET CITY: VICTORIA BC STATE: A1 ZIP: V8Z 7X8 4 1 wf-form4_164642818108100.xml FORM 4 X0306 4 2022-03-02 0 0001600620 Aurinia Pharmaceuticals Inc. AUPH 0001837648 Huizinga Robert Bindert #1203-4464 MARKHAM STREET VICTORIA A1 V8Z7X8 BRITISH COLUMBIA, CANADA 0 1 0 0 EVP of Research Common Stock 2022-03-02 4 A 0 8500 0 A 74228 D Common Stock 2022-03-02 4 S 0 4849 12.01 D 69379 D Restricted Stock Unit 2022-03-02 4 A 0 62448 0 A Common Shares 62448.0 62448 D Stock Option (right to buy) 12.01 2022-03-02 4 A 0 106838 0 A 2032-03-02 Common Stock 106838.0 106838 D On March 18, 2021, the Reporting Person was granted stock based performance awards ("Performance Awards") which vests when specific performance metrics are met based on the results for the year ended December 31, 2021. It was determined that as of March 2, 2022, the Reporting Person partially met the performance criteria and received shares of common stock for no consideration. Represents the number of shares sold to cover tax withholding obligations in connection with the vesting of Performance Awards. Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in three (3) equal annual installments beginning March 2, 2022, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date. One-third of the shares subject to the option vests twelve months from the grant date, and the remainder vests in twenty-four equal monthly installments thereafter. /s/ Robert Bindert Huizinga 2022-03-04